Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line

Solos Endoscopy, Inc. Receives Purchase Orders from University of California,
San Diego Medical Center for its MammoView(TM) Product Line

BOSTON, Oct. 29 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets:
SNDY) is pleased to announce that the Company has received purchase orders for
its MammoView(TM) line of surgical endoscopy instruments from University of
California, San Diego Medical Center, San Diego California. UCSD Medical
Center is highly regarded in the industry as it provides a significant amount
of healthcare in San Diego. UCSD Medical Center operates a network of
outpatient practices, free clinics and community-based services.

UCSD Medical Center was named among the best in the nation in six specialty
areas, in addition to possessing eighty physicians who earned a place in San
Diego Magazine's 2009 "Physicians of Exceptional Excellence." UCSD Medical
Center is home to one of just 39 National Cancer Institute-designated
Comprehensive Cancer Centers in the United States. Such centers are prominent
among the leading institutions in the nation dedicated to scientific
innovation and clinical excellence. UCSD is the only Comprehensive Cancer
Center in San Diego and Imperial counties to have earned this honor.

"We are extremely pleased to be a supplier to such a distinguished medical
institution that is one of the top health care providers in the United States.
We believe that our MammoView line will be instrumental in serving UCSD
Medical Center wellness initiatives," stated Bob Segersten, President of Solos
Endoscopy, Inc.

Solos Endoscopy recently announced that the Company has taken the initial
steps to get the CE Marking for its FDA approved MammoView(TM) line of
surgical instruments. This will allow the MammoView(TM) line to be sold
throughout the European Economic Union (EEU), which represents 30% or $94
Billion of the worldwide demand for medical instruments.

For more information on UCSD Medical Center, please visit: www.ucsd.edu

About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare technology company whose mission is to
develop and market breakthrough technology, applications, medical devices and
procedural techniques for the screening, diagnosis, treatment and management
of medical conditions. Backed by technical support, Solos' sales team can help
make the right buying decisions for the hospital, surgery center, or physician
office with its catalog of FDA Approved products. Additional information is
available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Statements contained in this release that are not
historical facts may be deemed to be forward-looking statements. Investors are
cautioned that forward-looking statements are inherently uncertain. Actual
performance and results may differ materially from that projected or suggested
herein due to certain risks and uncertainties including, without limitation,
ability to obtain financing and regulatory and shareholder approval for
anticipated actions.

SOURCE Solos Endoscopy, Inc.

Brian Neff, Investor Relations, Big Apple Consulting USA, +1-407-389-5900